Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,286 | Dovepress* | 12,193+ | 1,935 | 14,128 | |
PubMed Central* | 2,093 | 891 | 2,984 | ||
Totals | 14,286 | 2,826 | 17,112 | ||
*Since 15 April 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar